ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,067,000 | -63.6% | 798,873 | -77.3% | 0.37% | -58.1% |
| Q2 2019 | $41,405,000 | -4.8% | 3,517,856 | +10.4% | 0.87% | -15.0% |
| Q1 2019 | $43,488,000 | +50.5% | 3,185,983 | +13.0% | 1.03% | +49.6% |
| Q4 2018 | $28,892,000 | -9.4% | 2,818,788 | +47.2% | 0.69% | -4.7% |
| Q3 2018 | $31,879,000 | +23.4% | 1,914,690 | +17.1% | 0.72% | +19.4% |
| Q2 2018 | $25,834,000 | +261.3% | 1,635,035 | +190.4% | 0.60% | +284.7% |
| Q1 2018 | $7,151,000 | +89.8% | 563,037 | +210.8% | 0.16% | +80.5% |
| Q1 2017 | $3,768,000 | +0.6% | 181,143 | +0.6% | 0.09% | +2.4% |
| Q4 2016 | $3,744,000 | – | 180,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |